Page last updated: 2024-08-24

plerixafor and Severe Combined Immunodeficiency

plerixafor has been researched along with Severe Combined Immunodeficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowan, MJ; Czechowicz, A; Dvorak, CC; Horn, BN; Ko, RM; Puck, JM; Shizuru, JA1

Other Studies

1 other study(ies) available for plerixafor and Severe Combined Immunodeficiency

ArticleYear
A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
    Pediatric transplantation, 2014, Volume: 18, Issue:6

    Topics: Adolescent; Benzylamines; California; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclams; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Histocompatibility Testing; Humans; Infant; Male; Pilot Projects; Prospective Studies; Severe Combined Immunodeficiency; Transplantation Conditioning; Treatment Outcome

2014